21 Jan 2020 --- Increased competition in the space of nutritional hard capsules has negatively impacted Lonza Group’s fiscal 2019 profits, although the company reports overall strong sales... Read More

10 Jan 2020 --- In nutrition news this week, Catalent completed the purchase of Biologics Fill-Finish and Oral Solid Dose Facility, while KD Pharma rearranged and expanded its debt facilities,... Read More

10 Dec 2019 --- The majority of neonatal intensive care units (NICUs) participating in the Children’s Hospitals Neonatal Consortium are unable to reliably and consistently monitor caloric... Read More

09 Dec 2019 --- Brain scans are a key tool in enabling reformulators to create a product that consumers respond positively to at all levels of consciousness. This is according to Camilla Arndal... Read More

29 Nov 2019 --- A new three-strain probiotic blend from Chr. Hansen may help support intestinal health and development in preterm babies. It has been shown to reduce the risk of Necrotizing... Read More

Chr. Hansen has launched a new probiotic product which has the potential to improve the gut and immune health of infants and young children: probiotic drops containing Chr. Hansen’s bacteria strain BB-12 and sunflower oil.

Marie Brenoe of Chr. Hansen on Taking Probiotics to Juice Applications.

01 Feb 2016 --- Danish-headquartered Chr. Hansen has reported a strong start to the 2015/2016 financial year. An interview with Sten Estrup, VP at Chr. Hansen who talks about how new partnerships are indicative of how the company is investing in the future.

30 Nov 2014 --- Key suppliers offer their thoughts on the key dairy trends. How can manufacturers benefit from the mainstreaming of the sports nutrition sector? How can the boom in protein and the needs of the aging global population be addressed?

01 Mar 2013 --- Knud Vindfeldt: “Chr. Hansen has a clear strategy to obtain EU approved health claims for our core probiotic strains. While the EFSA demands are high and timelines have been challenging, this does not change our strategy. To protect our customers and consumers from conflicting messages, we will only submit our applications for health claims when we are confident we have sufficient data to meet the EFSA requirements.”

Mauricio Graber took the helm as new Chr. Hansen CEO on June 1, 2018, having previously served as President of the Flavours Division of Givaudan. Chr. Hansen recently reported its Q4 and full financial earnings. The company announced that it had achieved the overall financial targets set at the beginning of the year and raised its ambitions 9-11 percent organic growth for next year. It is the company’s core business of Cultures & Enzymes, which represents 59 percent of their business that performed the strongest, with bioprotection and probiotics forming key pillars here. FoodIngredientsFirst spoke with Mauricio about the current business environment and new opportunities for microbes.

Danish-headquartered ingredients supplier Chr. Hansen recently announced its annual results, with organic growth reported of 10 percent for 2016/2017. Food Cultures & Enzymes and Health & Nutrition both delivered strong growth, performing slightly above the long-term ambitions for these businesses, while Natural Colors grew in line with ambitions. The key focus for Chr. Hansen continues to be strong organic growth through innovation and the company notes that with good progress in many of its strategic initiatives, the building blocks for achieving its ambitious financial targets are in place.Soeren Westh Lonning, CFO at Chr. Hansen discusses the company’s strategy shortly after the results were announced.